pharmaceuticals

Timophey Nizhegorodtsev: modernizing the drug pricing methods creates conditions to reduce prices for the most expensive drugs
FAS insists on including price objectification measures in the pricing techniques and creating conditions that facilitate entry to the market of non-expensive drugs
more
Rachik Petrosyan: functionalities of the Informational Analytical System allow to expose overrated prices in drug procurement
IAS functionalities already enables to estimate average weighted prices for drug procurement per unit of active substance for a particular International Non-Proprietary Name, thanks to which it is possible to expose overrates prices in the course of drug procurement
more
Timophey Nizhegorodtsev: in drug distance selling pharmacies should form demand and deliver the medicines
This approach to drug distance selling will maintain competition on the market and prevent supervisory risks in drug circulation
more
Timophey Nizhegorodtsev presented Russian experience on reducing medicinal drug prices
Price reduction on average was 50% for 451 positions of expensive vital and essential medicinal drugs
more
Representatives of foreign competition authorities exchanged information abut the specifics of national regulation of drug prices
"The findings of the survey of world prices for medicines may form the basis for a wider comparison of medicinal drug pricing procedures in different jurisdictions” concluded Deputy Head of FAS Andrey Kashevarov.
more